Cumberland Pharmaceuticals (CPIX) Reports Q3 EPS of $0.02

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of $0.02. Revenue for the quarter came in at $10.08 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
• Dutch Bros Inc. (BROS) PT Raised to $90 at DA Davidson on Sales/Earnings Upside